Abstract
SO2 is emerging as a possible endogenous signaling molecule in mammals. In addition, SO2 has also shown pharmacological effects, presenting SO2 as a promising potential therapeutic agent. The past decade has witnessed steady advances in the development of small molecule-based SO2 prodrugs/donors with varied release mechanisms. Herein, we summarize various strategies employed for SO2 prodrug design. The remaining challenges and issues will also be discussed.
Keywords: Sulfur dioxide, Prodrugs, Drug delivery, Gasotransmitter, Donors, Click and release.
Graphical Abstract
Current Topics in Medicinal Chemistry
Title:Medicinal Chemistry Strategies Towards SO2 Donors as Research Tools and Potential Therapeutics
Volume: 21 Issue: 32
Author(s): Eman M El-Labbad*, Xingyue Ji*, Khaled A.M. Abouzid and Binghe Wang
Affiliation:
- Pharmaceutical Chemistry Department, Faculty of Pharmacy, Ain Shams University, Abbassia, 11566, Cairo,Egypt
- Department of Medicinal Chemistry, College of Pharmaceutical Science, Soochow University, 215123, Suzhou,China
Keywords: Sulfur dioxide, Prodrugs, Drug delivery, Gasotransmitter, Donors, Click and release.
Abstract: SO2 is emerging as a possible endogenous signaling molecule in mammals. In addition, SO2 has also shown pharmacological effects, presenting SO2 as a promising potential therapeutic agent. The past decade has witnessed steady advances in the development of small molecule-based SO2 prodrugs/donors with varied release mechanisms. Herein, we summarize various strategies employed for SO2 prodrug design. The remaining challenges and issues will also be discussed.
Export Options
About this article
Cite this article as:
El-Labbad M Eman *, Ji Xingyue *, Abouzid A.M. Khaled and Wang Binghe , Medicinal Chemistry Strategies Towards SO2 Donors as Research Tools and Potential Therapeutics, Current Topics in Medicinal Chemistry 2021; 21 (32) . https://dx.doi.org/10.2174/1568026621666211116091354
DOI https://dx.doi.org/10.2174/1568026621666211116091354 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting the p53 Pathway of Apoptosis
Current Pharmaceutical Design Urine IL-18 is a Biomarker of Early Acute Kidney Injury (AKI)
Recent Patents on Biomarkers Curcuminoid Metabolism and its Contribution to the Pharmacological Effects
Current Drug Metabolism Human Chorionic Gonadotropin: A Model Molecule For Oligopeptide-Based Drug Discovery
Endocrine, Metabolic & Immune Disorders - Drug Targets Intensive Glucose Control in Diabetics with an Acute Myocardial Infarction Does not Improve Mortality and Increases Risk of Hypoglycemia-A Meta-Regression Analysis
Current Vascular Pharmacology Molecular Imaging of Vascular Thrombosis
Current Molecular Imaging (Discontinued) Editorial (Hot Topic: Vascular Remodeling)
Current Vascular Pharmacology HspB8 is Neuroprotective during Oxygen Glucose Deprivation and Reperfusion
Current Neurovascular Research Protective Effect of Zinc on Mouse Renal Ischemia-reperfusion Injury by Anti-apoptosis and Antioxidation
Current Pharmaceutical Biotechnology Cardiovascular Proteomics
Current Proteomics “Letting the Air In” Can Set the Stage for Tumor Recurrences
Current Cancer Therapy Reviews The Role of Obesity in Cardiomyopathy and Nephropathy
Current Pharmaceutical Design Fatty Liver and Ischemia/Reperfusion: Are there Drugs Able to Mitigate Injury?
Current Medicinal Chemistry The Prostaglandin Agonist Beraprost Aggravates Doxorubicin-mediated Apoptosis by Increasing iNOS Expression in Cardiomyocytes
Current Vascular Pharmacology Rosiglitazone Does Not Improve Cognition or Global Function when Used as Adjunctive Therapy to AChE Inhibitors in Mild-to-Moderate Alzheimers Disease: Two Phase 3 Studies
Current Alzheimer Research The Epidemiology and Health Effects of Tobacco Use
Current Pediatric Reviews Orthostatic Hypotension: Evaluation and Treatment
Cardiovascular & Hematological Disorders-Drug Targets Evolving Strategies in Manipulating VEGF/VEGFR Signaling for the Promotion of Angiogenesis in Ischemic Muscle
Current Pharmaceutical Design Sex Hormones, Metabolic Syndrome and Kidney
Current Topics in Medicinal Chemistry Combinatorial Therapies for Cardiac Regeneration
Recent Patents on Regenerative Medicine